A retrospective cohort study by Ahmed et al. [108] recently evaluated whether antibiotic use during anti-PD-1 therapy affected the treatment outcome of patients with cancer (lung, renal, hepatocellular, head and neck, melanoma, urothelial cancers, etc.). The gene discussed is PDCD1; the disease is melanoma.